Equitec Proprietary Markets »

Keros Therapeutics shares owned by Equitec Proprietary Markets

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Equitec Proprietary Markets from 13F filings

Historical chart of Equitec Proprietary Markets investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Equitec Proprietary Markets consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Equitec Proprietary Markets

Quarter filed Position value Share count Share price at filing
2025-12-31 $371k 18k 20.36

More positions owned by Equitec Proprietary Markets

Netflix Call Option (NFLX)
Cidara Therapeutics Com New Call Option (CDTX)
Hologic (HOLX)
Avadel Pharmaceuticals Com Shs Call Option (AVDL)
Paramount Skydance Corp Com Cl B (PSKY)
Warner Bros Discovery Com Ser A (WBD)
Electronic Arts Call Option (EA)
Boeing Company Put Option (BA)
Brighthouse Finl (BHF)
Western Midstream Partners L Com Unit Lp Int (WES)
Kayne Anderson Bdc Com Shs (KBDC)
Siriusxm Holdings Common Stock (SIRI)
Wolfspeed Common Stock Put Option (WOLF)
Dynavax Technologies Corp Com New (DVAX)
Strategy Cl A New Call Option (MSTR)

View all positions for Equitec Proprietary Markets

Top funds holding Keros Therapeutics

BlackRock
Vanguard Group
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
State Street Corporation
Alkeon Capital Management
Madison Avenue Partners
OrbiMed Advisors
Qube Research & Technologies
Jacobs Levy Equity Management
Federated Investors
Geode Capital Management
Nantahala Capital Management
Renaissance Technologies
Goldman Sachs Group

View all funds holding Keros Therapeutics